Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
I am Intramural Blog

IRP’s Charles Rotimi Elected to American Academy of Arts and Sciences

Pioneering Genetic Epidemiologist Takes a Global Approach to Fighting Health Disparities

By Melissa Glim

Wednesday, June 16, 2021

Dr. Charles Rotimi

Dr. Charles Rotimi was elected to the American Academy of Arts and Sciences earlier this year for his research and leadership efforts to reduce health disparities in African populations.

IRP distinguished investigator Charles Rotimi, Ph.D., was elected to the American Academy of Arts and Sciences this year in recognition of his pioneering work exploring the health implications of genetic diversity in populations with African ancestry, as well as for globalizing the study of genomics, particularly in African nations. Dr. Rotimi joined NIH in 2008 as the founding director of the Intramural Center for Genomics and Health Disparities in the National Human Genome Research Institute (NHGRI), which was later renamed the Center for Research on Genomics and Global Health, in part to reflect Dr. Rotimi’s globe-spanning research programs.

“I've always been passionate about making sure that biomedical research, specifically genomic research, is applied to our global populations,” Dr. Rotimi says. “Whether we are deploying technology or training people, we should be looking at it from a global context so that we don’t exacerbate inequalities that already exist.”

When Dr. Rotimi arrived in the U.S. from Nigeria in 1982 to pursue a Master’s degree at the University of Mississippi, he quickly realized deep health disparities existed between populations in the United States, especially between African Americans and other groups. Ever since, he has devoted his career to understanding how the genetic, environmental, social, and cultural factors involved in metabolic diseases such as diabetes interact to affect health. Dr. Rotimi’s research is particularly motivated by a desire to understand how the genetic differences that emerged in geographically separated groups of humans during our evolutionary history influence health.

African American patient getting blood drawn

Due to a combination of genetic, environmental, and other factors, African Americans have higher rates of obesity, heart disease, and diabetes than other groups in the U.S.

“I’ve always been fascinated by the human history of how we share much of our heritage as human beings, but also the differences that we’ve developed to help us adapt to different environments,” he says.

Dr. Rotimi began his career in epidemiology soon after finishing his Ph.D. studies at the University of Alabama at Birmingham. While working in Alzheimer’s disease research as a postdoctoral fellow, he noticed an advertisement for an assistant professorship in epidemiology at Chicago’s Loyola University Medical Center. The ad seemed as if it had been written especially for him, and he immediately called the department head. He ultimately got the job and, in 1992, joined a Loyola University lab that investigated why rates of high blood pressure, diabetes, and obesity vary across populations of African ancestry in West Africa, the U.S. and the Caribbean.

Meanwhile, the Human Genome Project was making it possible for the first time to pinpoint the locations of genes involved in specific diseases. Soon after the first successes in mapping the human genome were announced in 2001, it became clear to Dr. Rotimi and many others in the genetics field that the next step would be to compare and understand how certain genes differ between different populations. This realization led to the development of the International HapMap project, which collected genetic samples from people across the globe and systematically documented variations in key areas of their genomes.

Dr. Anna Napoles

More From the IRP
Podcast
Dr. Anna Nápoles — A New Dawn for Minority Health

Dr. Rotimi, who had since moved to Howard University in Washington, D.C., became the principal investigator for the HapMap researchers’ collection efforts in three African communities in Nigeria and Kenya. Africa, he points out, is where human history began, and therefore where we could expect to find the oldest and most varied genetic profiles.

“For me, this work was really important to do because we wanted to make sure that we are indeed representing the huge genetic variation across African populations,” Dr. Rotimi says.

 DNA double helix made up of small pictures of people

By analyzing the genomes of large numbers of people from around the world, scientists like Dr. Rotimi can discover genetic variants that explain why some populations are more or less likely to develop certain diseases.

In 2003, Dr. Rotimi became the founding president of the African Society of Human Genetics (AfSHG), a group designed to engage African geneticists and researchers in a forum where they could meet, share ideas, and address issues of significance to them. Without such an organization, the Society’s founders worried, the genomic revolution might “fly over Africa like a lot of previous scientific revolutions had,” Dr. Rotimi explains.

Dr. Rotimi and AfSHG did more than provide a forum for researchers to connect, however. In 2009, the organization spearheaded an initiative called the Human Heredity & Health Africa (H3Africa) Initiative, sponsored by NIH and the Wellcome Trust. This project has provided more than $180 million to fund the development of infrastructure to support African-led genomics research, including funds for training scientists and building cutting-edge laboratories.

“As somebody who grew up in Nigeria and studied biochemistry there, I couldn't do my work because there were no good laboratories for me,” Dr. Rotimi says. “In H3Africa, I was extremely sensitive to the fact that we should specifically train African scientists so they don’t have to travel abroad to work.”

map showing genetic diversity in different continents

Image credit: Noah Rosenberg and Martin Soave, University of Michigan

Africa may be the most genetically diverse area in the world, as shown in this map of global human genetic variation.

Today, under Dr. Rotimi’s leadership, NHGRI’s Intramural Center for Research on Genomics and Global Health is continuing its work collaborating with global researchers to study disease-associated genetic variations in populations around the world, including in Africa, Asia, and South America. His own lab at NIH also follows this theme. For example, his team recently published research that used data from the long-standing Africa America Diabetes Mellitus (AADM) study to identify genetic risk factors for type 2 diabetes in more than 5,000 people living in Kenya, Nigeria, and Ghana. The study identified a gene involved in DNA replication and repair and showed that it is also important to ensuring the insulin-producing beta cells in the pancreas work properly. Insulin release is key to managing blood sugar levels in people with diabetes, and Dr. Rotimi’s team identified a variant of the gene that causes loss of beta cells and impairs surviving beta cells’ ability to produce insulin in response to high sugar levels, thereby increasing the risk of developing type 2 diabetes. The variant had not been found earlier because it is extremely rare in non-African populations.

Just as his research includes people from all parts of the globe, Dr. Rotimi has also brought the world to his lab. He takes great pride in training and engaging postdoctoral fellows from many different countries who bring a wide variety of perspectives and ideas to his team.

“This is really the best laboratory in terms of cultural and scientific background and the kind of questions that we ask,” says Dr. Rotimi. “That to me is very refreshing.”

Subscribe to our weekly newsletter to stay up-to-date on the latest breakthroughs in the NIH Intramural Research Program.


Category: Science
Tags: health disparities, honors, genetics, genes, diabetes, obesity, hypertension, genome, sequencing, DNA

Related Blog Posts

  • Duo Delves Into Genetics of Diabetes
  • A Multi-Front Effort to Combat Coronavirus
  • Understanding the Foundations of Immune Defenses
  • IRP Breast Cancer Researchers Answer “Redditor” Questions
  • African Ancestry May Influence Immune Response to Prostate Cancer

This page was last updated on Monday, February 7, 2022

Blog menu

  • Contributing Authors
    • Anindita Ray
    • Brandon Levy
    • Devon Valera
    • Melissa Glim
  • Categories
    • Collaboration
    • Science
    • Resources
    • Making a Difference
    • Careers

Blog links

  • Subscribe to RSS feed

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search